Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

• Auteurs principaux: Katja S. Just (Auteur), Catharina Scholl (Auteur), Miriam Boehme (Auteur), Kathrin Kastenmüller (Auteur), Johannes M. Just (Auteur), Markus Bleckwenn (Auteur), Stefan Holdenrieder (Auteur), Florian Meier (Auteur), Klaus Weckbecker (Auteur), Julia C. Stingl (Auteur)
• Format: Livre
• Publié: MDPI AG, 2021-10-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The aim of this study was to compare effects of an individualized with a standardized risk assessment for adverse drug reactions to improve drug treatment with antithrombotic drugs in older adults. A randomized controlled trial was conducted in general practitioner (GP) offices. Patients aged 60 yea...